CLINICAL_TRIALS
research
· 2010-02-25
Clinical Trial Update: The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression
Summary
A completed clinical trial investigated the role of the aromatic hydrocarbon receptor in neuroblastoma tumorigenesis and its relationship with MYCN expression.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Taiwan University Hospital | Conditions: Neuroblastoma | Status: COMPLETED